Processing math: 100%
Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Transformer-based transfer learning on self-reported voice recordings for Parkinson’s disease diagnosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Deep learning (DL) techniques are becoming more popular for diagnosing Parkinson’s disease (PD) because they offer non-invasive and easily accessible tools. By using advanced data analysis, these methods improve early detection and diagnosis, which is crucial for managing the disease effectively. This study explores end-to-end DL architectures, such as convolutional neural networks and transformers, for diagnosing PD using self-reported voice data collected via smartphones in everyday settings. Transfer learning was applied by starting with models pre-trained on large datasets from the image and the audio domains and then fine-tuning them on the mPower voice data. The Transformer model pre-trained on the voice data performed the best, achieving an average AUC of \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$95.89\%$$\end{document}

          and an average AUPRC of \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$87.11\%$$\end{document}
          , outperforming models trained from scratch. To the best of our knowledge, this is the first use of a Transformer model for audio data in PD diagnosis, using this dataset. We achieved better results than previous studies, whether they focused solely on the voice or incorporated multiple modalities, by relying only on the voice as a biomarker. These results show that using self-reported voice data with state-of-the-art DL architectures can significantly improve PD prediction and diagnosis, potentially leading to better patient outcomes.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          Parkinson disease

          Parkinson disease is the second-most common neurodegenerative disorder that affects 2-3% of the population ≥65 years of age. Neuronal loss in the substantia nigra, which causes striatal dopamine deficiency, and intracellular inclusions containing aggregates of α-synuclein are the neuropathological hallmarks of Parkinson disease. Multiple other cell types throughout the central and peripheral autonomic nervous system are also involved, probably from early disease onwards. Although clinical diagnosis relies on the presence of bradykinesia and other cardinal motor features, Parkinson disease is associated with many non-motor symptoms that add to overall disability. The underlying molecular pathogenesis involves multiple pathways and mechanisms: α-synuclein proteostasis, mitochondrial function, oxidative stress, calcium homeostasis, axonal transport and neuroinflammation. Recent research into diagnostic biomarkers has taken advantage of neuroimaging in which several modalities, including PET, single-photon emission CT (SPECT) and novel MRI techniques, have been shown to aid early and differential diagnosis. Treatment of Parkinson disease is anchored on pharmacological substitution of striatal dopamine, in addition to non-dopaminergic approaches to address both motor and non-motor symptoms and deep brain stimulation for those developing intractable L-DOPA-related motor complications. Experimental therapies have tried to restore striatal dopamine by gene-based and cell-based approaches, and most recently, aggregation and cellular transport of α-synuclein have become therapeutic targets. One of the greatest current challenges is to identify markers for prodromal disease stages, which would allow novel disease-modifying therapies to be started earlier.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Technology in Parkinson's disease: Challenges and opportunities.

            The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the "big data" acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. © 2016 International Parkinson and Movement Disorder Society.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.

              To evaluate the diagnostic accuracy of clinical diagnosis of Parkinson disease (PD) reported in the last 25 years by a systematic review and meta-analysis.
                Bookmark

                Author and article information

                Contributors
                ilias.tougui@uir.ac.ma
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                3 December 2024
                3 December 2024
                2024
                : 14
                : 30131
                Affiliations
                [1 ]College of Engineering and Architecture - TICLab, International University of Rabat, ( https://ror.org/01t9czq80) Rabat, Morocco
                [2 ]Faculty of Engineering, University of Leeds, ( https://ror.org/024mrxd33) Leeds, UK
                Article
                81824
                10.1038/s41598-024-81824-x
                11614913
                39627487
                00491bc5-17b9-4472-8da3-fe419cded71b
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

                History
                : 14 August 2024
                : 29 November 2024
                Categories
                Article
                Custom metadata
                © Springer Nature Limited 2024

                Uncategorized
                parkinson’s disease,voice data,deep learning,transfer learning,fine-tuning,transformers,parkinson's disease,computational science

                Comments

                Comment on this article